Navigation Links
Test for prenatal chromosomal abnormalities using cervical swab,,

Australian researchers have discovered a new method to test for prenatal chromosomal// abnormalities using cervical swabs.

Testing fetus for chromosomal abnormalities are currently done through amniocentesis and other methods of screenings. In their new research, the scientists have been able to isolate single cells of the fetus from the cervical mucus of the pregnant woman with the help of a cervical swab. This may be done between 7 and 10 weeks into the pregnancy.

Researchers have used an enzyme to free up the cell and fluorescent antibodies to mark the fetal cells. These cells are then checked for chromosomal abnormalities with the help of DNA identification. The abnormalities of chromosome may be giving rise to Down’s syndrome etc. early identification of which is essential.

This test will be the first of its kind, being noninvasive test for chromosomal abnormalities, and may be used for both low risk and high risk pregnancies. The method of testing is also fast and quick, with results made available within 24 hrs of the test.

The research report is published in the British Journal of Obstetrics and Gynecology.
'"/>




Page: 1

Related medicine news :

1. No harm in reducing prenatal check up to 3 - 6 times says WHO report
2. Prenatal exposure to air pollution causes chromosomal damage
3. Obese children may have abnormalities of lipoproteins
4. Finger And Toe abnormalities Related to Maternal Smoking
5. Poor health care in Russia maybe causing Decline in its Population
6. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
7. Researchers urge caution in using ear tube surgery
8. Relief to pregnant women using fertility drugs
9. The hazards of using disinfectant hand gel
10. Ulcer causing bug found in stored food
11. Colon cancer risk linked to genes causing Hemochromatosis
Post Your Comments:
(Date:7/25/2008)...benefit ALS Therapy Alliance to be presented at Fe... WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/pha... a record-breaking $4.4 million in just 21 days,th... ALS research. This is,the seventh year of the ann...more than $15 million for ALS research. This year,...
(Date:7/25/2008)... New program delivers immediate cost s...hour telephone access to language interpreters] t...ltilingual solutions. , W...reg; http://www.lle-inc.com/index.html [(Languag... of interpretation, translation, and language inst...
(Date:7/25/2008)... This donation will be used to facilit...ervices for children , Ha...ww.ivci.com ), a leading integrator of enterprise... video conferencing, telepresence, audio visual in...unced today that it has donated video conferencing...
(Date:7/24/2008)...N, July 24 /PRNewswire-USNewswire/ -- Speaker Nanc...ning in support of the Tom Lantos,and Henry J. Hyd..., and,Malaria Reauthorization Act of 2008. The bil...ouse this evening by a vote of 303 to 115 and will... "Today the House took an historic vote to pass l...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2
...birth do survive into adolescence, a study conduct...lly it is believed that virtually all children inf.... But doctors working in sub-Saharan Africa have b...dmitted in HIV clinics. Researchers from the Well...
...bs with the NHS in the last quarter of 2006.The to...as per official statistics//. The job-cuts may be ...take a toll on patient care. Most of the redunda... category. Nevertheless, for those who have lost t...
...es cause a bizarre but dangerous side effect -- sl...n (FDA) has warned. Those who take the pills co...y may have no memory of having taken a tablet at a...g phone calls or fixing and eating food even while...
...which was in use even in ancient civilizations, ...//hospital settings. Scientists of the NHS who a...ich are taking over many hospitals across U.K, are...erial properties of this metal to use. Selly Oaks...
Other Medicine News:Health News:Trial Run of Copper to Combat MRSA 2
(Date:7/23/2008)...erapy to Treat the Disease -, WAYNE, N.J. and EME...,Bayer HealthCare Pharmaceuticals and Onyx Pharmac... The New England Journal of Medicine published,res...(R) (sorafenib),tablets decreased the absolute ris...able hepatocellular carcinoma (HCC), or liver canc...
(Date:7/23/2008)... Have Greater Concentrations of,Stem Cells, ARLIN.../ -- Fat removed,from the lower abdomen and inner ...lent source of stem cells, with higher stem cell c...s a Brazilian-based study in August,s,Plastic and ...urnal of the,American Society of Plastic Surgeons ...
(Date:7/22/2008)...center 293-patient European, trial -, http://ww...YT, MONTREAL, July 22 / Cr...cryotherapy products to treat cardiac,arrhythmias,... from three,European study centers using the Compa... earlier today in the Journal of the American Coll...
(Date:7/22/2008)...ma Exhibits Excellent Drug-Like ...itiation of Phase II Clinical Trials -, RESEARCH ...x BioPharma,Inc., a clinical stage company develo... diseases of the central nervous system, today ann...TM) into Phase II trials for the,treatment of depr...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Novo Nordisk Settles With Pfizer On Patent Infringement Suit 8008 1CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 1CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 2CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 3CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 4CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 5CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 6CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 7Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 1Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 2Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 3Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 4FDLI PEN co sponsor major conference on nanotechnology 1536 1FDLI PEN co sponsor major conference on nanotechnology 1536 2FDLI PEN co sponsor major conference on nanotechnology 1536 3
...est, Most Comprehensive Survey Provides New Benchm...June 21, 2007 /PRNewswire-USNewswire/ -- The,follo... -- First nationwide study of the prevalence of M... (MRSA), a virulent multi-drug resistant organism,...RSA prevalence study findings significantly exceed...
...TAIN VIEW, Calif., June 22, 2007 /PRNewswire/ -- M...ill present Phase 2,data from its Unit Dose Budeso...am at the World Asthma Meeting at the Lutfi Kirdar...key. , The oral and poster presentation entitled, ... formulation of budesonide for,nebulized delivery ...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2
Craniosorb Absorbable Fixation System (AFS) is uniquely designed to offer simple and reproducible fixation of the cranial flap and allow for complete absorption of the plating system over time.
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric
By combining intra-operative ultrasound imaging with preoperative imagery, Medtronic Surgical Navigation Technologies has created a revolutionary product called SonoNav Intra-operative Imaging System
...oglue) is a two-component surgical adhesive compos...araldehyde. The BSA is obtained from cattle exclus...free countries and undergoes processing that reduc...nsed by a controlled delivery system, composed of ...
Medicine Products: